Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer

C Palmberg; P Koivisto; L Kakkola; TLJ Tammela; O-P Kallioniemi; T Visakorpi

doi:10.1016/s0022-5347(05)66935-2

Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer

C Palmberg, P Koivisto, L Kakkola, TLJ Tammela, O-P Kallioniemi, T Visakorpi

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Pages (from-to)	1992-1995
Journal	J Urol
Volume	164
Issue number	6
DOIs	https://doi.org/10.1016/s0022-5347(05)66935-2
Publication status	Published - 2000
Publication type	A1 Journal article-refereed

Access to Document

10.1016/s0022-5347(05)66935-2

Cite this

@article{957616dafb534fa2ac9b72e972cbfda4,

title = "Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer",

author = "C Palmberg and P Koivisto and L Kakkola and TLJ Tammela and O-P Kallioniemi and T Visakorpi",

year = "2000",

doi = "10.1016/s0022-5347(05)66935-2",

language = "English",

volume = "164",

pages = "1992--1995",

number = "6",

}

Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer. / Palmberg, C; Koivisto, P; Kakkola, L; Tammela, TLJ; Kallioniemi, O-P; Visakorpi, T.

In: J Urol, Vol. 164, No. 6, 2000, p. 1992-1995.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer

AU - Palmberg, C

AU - Koivisto, P

AU - Kakkola, L

AU - Tammela, TLJ

AU - Kallioniemi, O-P

AU - Visakorpi, T

PY - 2000

Y1 - 2000

U2 - 10.1016/s0022-5347(05)66935-2

DO - 10.1016/s0022-5347(05)66935-2

M3 - Article

VL - 164

SP - 1992

EP - 1995

IS - 6

ER -